Skip to content
PICO Portalanswers from OpenAlex

Prevalence and reversibility of lower airway obstruction in children with sickle cell disease

PaperCitations, authors & open-access status

Prevalence and reversibility of lower airway obstruction in children with sickle cell disease is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prevalence and reversibility of lower airway obstruction in children with sickle cell disease have?

PICO Portalcitation count

Prevalence and reversibility of lower airway obstruction in children with sickle cell disease has 177 citations in the OpenAlex counts PICO Portal stores.

When was Prevalence and reversibility of lower airway obstruction in children with sickle cell disease published?

PICO Portalyear

Prevalence and reversibility of lower airway obstruction in children with sickle cell disease has 2001 year in the PICO Portal index.

What is the open-access status of Prevalence and reversibility of lower airway obstruction in children with sickle cell disease?

PICO Portaloa status

Prevalence and reversibility of lower airway obstruction in children with sickle cell disease has closed oa status in the PICO Portal index.

What is the DOI of Prevalence and reversibility of lower airway obstruction in children with sickle cell disease?

PICO Portaldoi

The DOI for Prevalence and reversibility of lower airway obstruction in children with sickle cell disease is on the source record.

What is the PMID of Prevalence and reversibility of lower airway obstruction in children with sickle cell disease?

PICO Portalpmid

The PMID for Prevalence and reversibility of lower airway obstruction in children with sickle cell disease is on the source record.

What is the OpenAlex record for Prevalence and reversibility of lower airway obstruction in children with sickle cell disease?

PICO Portalopenalex

The OpenAlex for Prevalence and reversibility of lower airway obstruction in children with sickle cell disease is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial